Cys-HAP-1
Cys-HAP-1 is a synovium-homing peptide that specifically binds to human and rabbit fibroblast-like synoviocytes, and does not bind to human umbilical vein endothelial cells regardless of TNF-α treatment. Cys-HAP-1 enables targeted drug delivery to inflamed joints after conjugation with liposomes loaded with anti-arthritic agents. Cys-HAP-1 can be used in studies related to adjuvant arthritis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C63H95N19O18S
- Masse moléculaire:1438.61
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Chemical Information
-
Masse moléculaire 1438.61
-
Formule C63H95N19O18S
-
Sequence
Cys-Ser-Phe-His-Gln-Phe-Ala-Arg-Ala-Thr-Leu-Ala-Ser
-
Sequence Shortening
CSFHQFARATLAS
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Cys-HAP-1
- Others
- synovium
- anti-arthritic agents
- rabbit fibroblast-like synoviocytes (rFLS)
- fibroblast-like synoviocytes
- TNF-α
- human fibroblast-like synoviocytes (hFLS)
- inflamed joints
- rat adjuvant-induced arthritis model
- adjuvant-induced arthritis
- human umbilical vein endothelial cells
- Inhibitor
- inhibitor
- inhibit